Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sibylle C Mellinghoff

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Infection|December 17, 2024
Respiratory syncytial virus infection in patients with haematological diseases: a retrospective multicentre studySebastian Herrmann, Stephanie Graefe, Maximilian Christopeit, et al.
Mycoses|December 27, 2019
Quantifying guideline adherence in mucormycosis management using the EQUAL scorePhilipp Koehler, Sibylle C Mellinghoff, Jannik Stemler, et al.
European Journal of Haematology|February 4, 2024
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemiaSibylle C Mellinghoff, Sandra Robrecht, Rosanne Sprute, et al.
Cancer Cell|May 5, 2022
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT studyMartin Schönlein, Victoria Wrage, Susanne Ghandili, et al.
BMC Medical Research Methodology|August 12, 2022
Harmonized procedure coding system for surgical procedures and analysis of surgical site infections (SSI) of five European countriesSibylle C Mellinghoff, Caroline Bruns, Rouvier Al-Monajjed, et al.
Annals of Hematology|January 21, 2026
Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)Nicola Giesen, Sibylle C Mellinghoff, Elham Khatamzas, et al.
Annals of Hematology|December 9, 2017
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Sibylle C Mellinghoff, Jens Panse, Nael Alakel, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2023
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variantsNicola Giesen, Elena Busch, Enrico Schalk, et al.
The Lancet Regional Health. Europe|February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignanciesMichael Sandherr, Jannik Stemler, Enrico Schalk, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Infection|December 17, 2024
Respiratory syncytial virus infection in patients with haematological diseases: a retrospective multicentre studySebastian Herrmann, Stephanie Graefe, Maximilian Christopeit, et al.
Mycoses|December 27, 2019
Quantifying guideline adherence in mucormycosis management using the EQUAL scorePhilipp Koehler, Sibylle C Mellinghoff, Jannik Stemler, et al.
European Journal of Haematology|February 4, 2024
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemiaSibylle C Mellinghoff, Sandra Robrecht, Rosanne Sprute, et al.
Cancer Cell|May 5, 2022
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT studyMartin Schönlein, Victoria Wrage, Susanne Ghandili, et al.
BMC Medical Research Methodology|August 12, 2022
Harmonized procedure coding system for surgical procedures and analysis of surgical site infections (SSI) of five European countriesSibylle C Mellinghoff, Caroline Bruns, Rouvier Al-Monajjed, et al.
Annals of Hematology|January 21, 2026
Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)Nicola Giesen, Sibylle C Mellinghoff, Elham Khatamzas, et al.
Annals of Hematology|December 9, 2017
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Sibylle C Mellinghoff, Jens Panse, Nael Alakel, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2023
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variantsNicola Giesen, Elena Busch, Enrico Schalk, et al.
The Lancet Regional Health. Europe|February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignanciesMichael Sandherr, Jannik Stemler, Enrico Schalk, et al.
Pageof 8